Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death

Journal of Neuroscience

Volumn 28, Issue 48, 2008, Pages 12604-12613

  Hee, Jung Kim ^a   Martemyanov, Kirill A ^a   Thayer, Stanley A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

LRP; NeuroAIDs; Neurotoxicity; Proteasome; PSD95; Tat

Indexed keywords

GREEN FLUORESCENT PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; NUTLIN 3; POSTSYNAPTIC DENSITY PROTEIN 95; TRANSACTIVATOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HIPPOCAMPUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; UBIQUITINATION;

AIDS DEMENTIA COMPLEX; ANIMALS; BIOLOGICAL ASSAY; BRAIN; CALCIUM SIGNALING; CELLS, CULTURED; DOWN-REGULATION; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HIV; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; MEMBRANE PROTEINS; NERVE DEGENERATION; NEURONS; RATS; RECEPTORS, LDL; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES; SYNAPTIC MEMBRANES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 58149388886     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2958-08.2008     Document Type: Article

References (64)

1. Adle-Biassette H, Chrétien F, Wingertsmann L, Héry C, Ereau T, Scaravilli F, Tardieu M, Gray F (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 25:123-133.
2. Albensi BC (2007) TheNMDAreceptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicity. Curr Pharm Des 13:3185-3194.
3. Anderson ER, Gendelman HE, Xiong H (2004) Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J Neurosci 24:7194 -7198.
4. Aprea S, Del Valle L, Mameli G, Sawaya BE, Khalili K, Peruzzi F (2006) Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci 26:4054-4062.
5. Arnold DB, Clapham DE (1999) Molecular determinants for subcellular localization of PSD-95 with an interacting K+ channel. Neuron 23:149 -157.
6. Bacskai BJ, Xia MQ, Strickland DK, Rebeck GW, Hyman BT (2000) The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 97:11551-11556.
7. Bellizzi MJ, Lu SM, Gelbard HA (2006) Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. J Neuroimmune Pharmacol 1:20 -31.
8. Bingol B, Schuman EM (2006) Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 441:1144 -1148.
9. Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G (2001) HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 288:301-308.
10. Brès V, Kiernan RE, Linares LK, Chable-Bessia C, Plechakova O, Tréand C, Emiliani S, Peloponese JM, Jeang KT, Coux O, Scheffner M, BenkiraneM (2003) A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol 5:754 -761.
11. Bu G (2001) The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family. Intl Rev Cytology 209:79 -116.
12. Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, Khan K, Seubert P, Freedman S, Schenk D, Games D (2005) Betaamyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci 25:9096 -9101.
13. Colledge M, Snyder EM, Crozier RA, Soderling JA, Jin Y, Langeberg LK, Lu H, Bear MF, Scott JD (2003) Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 40:595- 607.
14. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C (1998) HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4:1182-1184.
15. Desai NS (2003) Homeostatic plasticity in the CNS: synaptic and intrinsic forms. J Physiol Paris 97:391- 402.
16. EhlersMD (2003) Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 6:231-242.
17. Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW (2007) HIV-Tat induces formation of an LRP-PSD-95- NMDARnNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci U S A 104:3438 -3443.
18. Fiala JC, Spacek J, Harris KM (2002) Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Rev 39:29 -54.
19. Finkbeiner S, Cuervo AM, Morimoto RI, Muchowski PJ (2006) Diseasemodifying pathways in neurodegeneration. J Neurosci 26:10349 -10357.
20. Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189 -1193.
21. Gendelman HE (2007) Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders. J Neuroimmune Pharmacol 2:8 -13.
22. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-1718.
23. Gilbert GL, Kim HJ, Waataja JJ, Thayer SA (2007) Delta9- tetrahydrocannabinol protects hippocampal neurons from excitotoxicity. Brain Res 1128:61- 69.
24. Hasbani MJ, Schlief ML, Fisher DA, Goldberg MP (2001) Dendritic spines lost during glutamate receptor activation reemerge at original sites of synaptic contact. J Neurosci 21:2393-2403.
25. Haughey NJ, Mattson MP (2002) Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. JAIDS 31:S55-S61.
26. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 78:457- 467.
27. Herz J, Chen Y (2006) Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 7:850-859.
28. Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I (2000) Detection of the human immunodeficiency virus regulatory protein Tat in CNS tissues. J Neurovirol 6:145-155.
29. Hult B, Chana G, Masliah E, Everall I (2008) Neurobiology of HIV. Int Rev Psychiatry 20:3-13.
30. Kaul M, Lipton SA (2006) Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4:307-318.
31. Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ (2003) Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 162:1693-1707.
32. Kim HJ, Waataja JJ, Thayer SA (2008) Cannabinoids inhibit networkdriven synapse loss between hippocampal neurons in culture. J Pharmacol Exp Ther 325:850-858.
33. King JE, Eugenin EA, Buckner CM, Berman JW (2006) HIV Tat and neurotoxicity. Microbes Infect 8:1347-1357.
34. Kruman II, Nath A, MattsonMP (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154:276 -288.
35. Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I (2006) Lithium improves HIV-associated neurocognitive impairment. AIDS 20:1885-1888.
36. Li ST, Matsushita M, Moriwaki A, Saheki Y, Lu YF, Tomizawa K, Wu HY, Terada H, Matsui H (2004) HIV-1 Tat inhibits long-term potentiation and attenuates spatial learning. Ann Neurol 55:362-371.
37. Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A, He JJ (2000) Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6:1380 -1387.
38. Maragos WF, Tillman P, Jones M, Bruce-Keller AJ, Roth S, Bell JE, Nath A (2003) Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat. Neuroscience 117:43-53.
39. Masliah E, Terry R (1993) The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 3:77- 85.
40. Mattson MP, Haughey NJ, Nath A (2005) Cell death in HIV dementia. Cell Death Differ 12 [Suppl 1]:893-904.
41. May P, Woldt E, Matz RL, Boucher P (2007) The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med 39:219 -228.
42. Meller R, Thompson SJ, Lusardi TA, Ordonez AN, Ashley MD, Jessick V, Wang W, Torrey DJ, Henshall DC, Gafken PR, Saugstad JA, Xiong ZG, Simon RP (2008) Ubiquitin Proteasome-Mediated Synaptic Reorganization: A Novel Mechanism Underlying Rapid Ischemic Tolerance. J Neurosci 28:50 -59.
43. Minagar A, Commins D, Alexander JS, Hoque R, Chiappelli F, Singer EJ, Nikbin B, Shapshak P (2008) NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Molecular diagnosis and therapy 12:25- 43.
44. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 70:1475-1480.
45. Nath A, Conant K, Chen P, Scott C, Major EO (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 274:17098 -17102.
46. Perez A, Probert AW, Wang KK, Sharmeen L (2001) Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol 7:1-10.
47. Peterson C, Neal JH, Cotman CW (1989) Development of N-methyl-Daspartate excitotoxicity in cultured hippocampal neurons. Brain Res Dev Brain Res 48:187-195.
48. PrendergastMA,Rogers DT, Mulholland PJ, Littleton JM, WilkinsLHJr, Self RL, Nath A (2002) Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-aspartate receptor. Brain Res 954:300-307.
49. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586 -592.
50. Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21:267-271.
51. Sa MJ, Madeira MD, Ruela C, Volk B, Mota-Miranda A, Paula-BarbosaMM (2004) Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol (Berl) 107:97-110.
52. Schellenberg GD, D'Souza I, Poorkaj P (2000) The genetics of Alzheimer's disease. Current psychiatry reports 2:158 -164.
53. Self RL, Mulholland PJ, Nath A, Harris BR, Prendergast MA (2004) The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular is Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Brain Res 995:39-45.
54. Shen M, Thayer SA (1998a) Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 54:459-462.
55. Shen M, Thayer SA (1998b) The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res 783:77- 84.
56. Song L, Nath A, Geiger JD, Moore A, Hochman S (2003) Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J Neurovirol 9:399-403.
57. Speth C, Stöckl G, Mohsenipour I, Würzner R, Stoiber H, Lass-Flörl C, Dierich MP (2001) Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes. J Virol 75:2604 -2615.
58. Swann JW, Al-Noori S, Jiang M, Lee CL (2000) Spine loss and other dendritic abnormalities in epilepsy. Hippocampus 10:617- 625.
59. Tymianski M, Spigelman I, Zhang L, Carlen PL, Tator CH, Charlton MP, Wallace MC (1994) Mechanism of action and persistence of neuroprotection by cell-permeant Ca2+ chelators. J Cereb Blood Flow Metab 14:911-923.
60. Uo T, Kinoshita Y, Morrison RS (2007) Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/ cytoplasmic site of action in postnatal cortical neurons. J Neurosci 27:12198 -12210.
61. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844-848.
62. Waataja JJ, Kim HJ, Roloff AM, Thayer SA (2008) Excitotoxic loss of postsynaptic sites is distinct temporally and mechanistically from neuronal death. J Neurochem 104:364 -375.
63. Zhang Y, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734.
64. Zink WE, Anderson E, Boyle J, Hock L, Rodriguez-Sierra J, Xiong H, Gendelman HE, Persidsky Y (2002) Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci 22:2096 -2105.